Robert W. Ross is Chief Executive Officer of Surface Oncology, Inc.
Person profile
Roles
Surface Oncology
Chief Executive Officer
Xilio Therapeutics
Director
Address
Cambridge, Massachusetts
Employees
SEC CIK
Latest filings (excl ownership)
No filings
Latest ownership filings
4
Surface Oncology, Inc.
8 Sep 23
4
Surface Oncology, Inc.
11 Aug 23
4
Xilio Therapeutics, Inc.
13 Jun 23
4
Surface Oncology, Inc.
3 Mar 23
4
Surface Oncology, Inc.
5 Aug 22
4
Xilio Therapeutics, Inc.
17 Jun 22
3
Xilio Therapeutics, Inc.
17 Jun 22
4
Surface Oncology, Inc.
3 Mar 22
4
Surface Oncology, Inc.
14 Jan 22
4/A
Surface Oncology, Inc.
11 Mar 21
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
8 Sep 23 | SURF Surface Oncology | Common Stock | Sale back to company | Dispose D | No | No | 0 | 83,193 | 0.00 | 0 |
8 Sep 23 | SURF Surface Oncology | Stock Option Common Stock | Sale back to company | Dispose D | No | No | 0.69 | 400,000 | 276.00 k | 0 |
1 Aug 23 | SURF Surface Oncology | Common Stock | Sell | Dispose S | No | No | 0.94 | 16,713 | 15.71 k | 83,193 |
12 Jun 23 | XLO Xilio Therapeutics | Stock Option Common Stock | Grant | Acquire A | No | No | 2.8 | 13,200 | 36.96 k | 13,200 |
1 Mar 23 | SURF Surface Oncology | Stock Option Common Stock | Grant | Acquire A | No | No | 0.69 | 400,000 | 276.00 k | 400,000 |